Abstract
Patients receiving spinal cord stimulation (SCS) therapy require frequent reprogramming following device implantation to achieve optimal pain management and commonly encounter therapy disruptions.1-3 Delays scheduling in-clinic visits are common and may extend periods of pain relapse and contribute to worsening outcomes.4,5 Further, evidence suggests pain intensity reported during in-clinic assessments may be inconsistent with at-home daily reports, and may not fully reflect SCS patient experience in real-world settings.6,7 The BENEFIT-03 Study (NCT04683718) is designed to evaluate the safety and effectiveness of an implantable SCS system with automated remote device monitoring, remote programming and multiphase stimulation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
